Scientific letter
Lixisenatide clinical experience on patients with type 2 diabetes and obesity in endocrinology offices in Malaga
Experiencia clínica con lixisenatida en pacientes con diabetes tipo 2 y obesidad en consultas de atención especializada en Málaga
Read
3563
Timeswas read the article
1034
Total PDF
2529
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 24 | 5 | 29 |
| 2025 11 | 88 | 55 | 143 |
| 2025 10 | 54 | 15 | 69 |
| 2025 9 | 51 | 18 | 69 |
| 2025 8 | 43 | 14 | 57 |
| 2025 7 | 46 | 11 | 57 |
| 2025 6 | 56 | 7 | 63 |
| 2025 5 | 39 | 2 | 41 |
| 2025 4 | 27 | 4 | 31 |
| 2025 3 | 34 | 5 | 39 |
| 2025 2 | 29 | 9 | 38 |
| 2025 1 | 30 | 3 | 33 |
| 2024 12 | 24 | 2 | 26 |
| 2024 11 | 30 | 7 | 37 |
| 2024 10 | 13 | 1 | 14 |
| 2024 9 | 13 | 3 | 16 |
| 2024 8 | 13 | 4 | 17 |
| 2024 7 | 20 | 3 | 23 |
| 2024 6 | 9 | 2 | 11 |
| 2024 5 | 12 | 2 | 14 |
| 2024 4 | 25 | 7 | 32 |
| 2024 3 | 28 | 6 | 34 |
| 2024 2 | 15 | 7 | 22 |
| 2024 1 | 15 | 3 | 18 |
| 2023 12 | 14 | 8 | 22 |
| 2023 11 | 22 | 6 | 28 |
| 2023 10 | 21 | 12 | 33 |
| 2023 9 | 19 | 1 | 20 |
| 2023 8 | 12 | 3 | 15 |
| 2023 7 | 13 | 19 | 32 |
| 2023 6 | 22 | 2 | 24 |
| 2023 5 | 22 | 7 | 29 |
| 2023 4 | 32 | 3 | 35 |
| 2023 3 | 13 | 5 | 18 |
| 2023 2 | 25 | 12 | 37 |
| 2023 1 | 15 | 15 | 30 |
| 2022 12 | 9 | 8 | 17 |
| 2022 11 | 26 | 13 | 39 |
| 2022 10 | 23 | 9 | 32 |
| 2022 9 | 16 | 10 | 26 |
| 2022 8 | 20 | 9 | 29 |
| 2022 7 | 17 | 7 | 24 |
| 2022 6 | 14 | 8 | 22 |
| 2022 5 | 19 | 15 | 34 |
| 2022 4 | 27 | 15 | 42 |
| 2022 3 | 19 | 12 | 31 |
| 2022 2 | 14 | 8 | 22 |
| 2022 1 | 47 | 7 | 54 |
| 2021 12 | 22 | 9 | 31 |
| 2021 11 | 19 | 9 | 28 |
| 2021 10 | 25 | 9 | 34 |
| 2021 9 | 8 | 15 | 23 |
| 2021 8 | 9 | 7 | 16 |
| 2021 7 | 13 | 6 | 19 |
| 2021 6 | 14 | 7 | 21 |
| 2021 5 | 20 | 7 | 27 |
| 2021 4 | 42 | 36 | 78 |
| 2021 3 | 11 | 11 | 22 |
| 2021 2 | 10 | 6 | 16 |
| 2021 1 | 19 | 11 | 30 |
| 2020 12 | 12 | 9 | 21 |
| 2020 11 | 16 | 10 | 26 |
| 2020 10 | 13 | 8 | 21 |
| 2020 9 | 16 | 9 | 25 |
| 2020 8 | 20 | 11 | 31 |
| 2020 7 | 14 | 11 | 25 |
| 2020 6 | 6 | 10 | 16 |
| 2020 5 | 21 | 12 | 33 |
| 2020 4 | 12 | 2 | 14 |
| 2020 3 | 17 | 2 | 19 |
| 2020 2 | 21 | 8 | 29 |
| 2020 1 | 20 | 6 | 26 |
| 2019 12 | 11 | 13 | 24 |
| 2019 11 | 16 | 13 | 29 |
| 2019 10 | 17 | 7 | 24 |
| 2019 9 | 32 | 5 | 37 |
| 2019 8 | 15 | 10 | 25 |
| 2019 7 | 27 | 20 | 47 |
| 2019 6 | 40 | 41 | 81 |
| 2019 5 | 120 | 65 | 185 |
| 2019 4 | 44 | 32 | 76 |
| 2019 3 | 11 | 7 | 18 |
| 2019 2 | 8 | 12 | 20 |
| 2019 1 | 6 | 2 | 8 |
| 2018 12 | 15 | 4 | 19 |
| 2018 11 | 14 | 6 | 20 |
| 2018 10 | 20 | 2 | 22 |
| 2018 9 | 13 | 15 | 28 |
| 2018 8 | 1 | 9 | 10 |
| 2018 7 | 3 | 4 | 7 |
| 2018 6 | 6 | 2 | 8 |
| 2018 5 | 11 | 8 | 19 |
| 2018 4 | 8 | 0 | 8 |
| 2018 3 | 9 | 1 | 10 |
| 2018 2 | 11 | 3 | 14 |
| 2018 1 | 12 | 1 | 13 |
| 2017 12 | 9 | 1 | 10 |
| 2017 11 | 9 | 3 | 12 |
| 2017 10 | 11 | 2 | 13 |
| 2017 9 | 13 | 3 | 16 |
| 2017 8 | 16 | 12 | 28 |
| 2017 7 | 12 | 2 | 14 |
| 2017 6 | 24 | 14 | 38 |
| 2017 5 | 24 | 3 | 27 |
| 2017 4 | 15 | 15 | 30 |
| 2017 3 | 22 | 2 | 24 |
| 2017 2 | 47 | 5 | 52 |
| 2017 1 | 21 | 4 | 25 |
| 2016 12 | 19 | 3 | 22 |
| 2016 11 | 26 | 6 | 32 |
| 2016 10 | 39 | 8 | 47 |
| 2016 9 | 53 | 8 | 61 |
| 2016 8 | 26 | 8 | 34 |
| 2016 7 | 27 | 1 | 28 |
| 2016 6 | 26 | 8 | 34 |
| 2016 5 | 1 | 0 | 1 |
| 2016 3 | 0 | 2 | 2 |
| 2016 1 | 0 | 1 | 1 |
| 2015 12 | 0 | 1 | 1 |
Show all
